Cepheid has introduced the GeneXpert ® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology. The latest addition to Cepheid's GeneXpert ® family of real-time PCR devices ...

Cepheid, a leading molecular diagnostics company, and FIND, an international non-profit organisation, launched the GeneXpert Omni, the world's most portable molecular diagnostics system enabling ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif., ...

Though the global number of recorded monkeypox cases continues to climb—passing 4,100 last week, according to the Centers for Disease Control and Prevention (CDC)—many researchers and epidemiologists ...

GeneXpert Anthrax tests combine sample preparation with real-time PCR (polymerase chain reaction) amplification and detection for fully automated DNA analysis. The system purifies, concentrates, ...

A Birmingham company is working with Cepheid to develop a PCR test for monkeypox, a virus that has spread to the U.S., though the CDC classifies the threat as low. Birmingham-based BioGX is ...

Firm claims assay can differentiate between flu A, flu B, and 2009 H1N1 in under an hour. Cepheid launched its CE-marked Xpert® Flu in vitro diagnostic in Europe. The test, designed to run on the ...

SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the ...

SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases The two companies have completed a successful ...